GlassScriptPhysician profile
David M Chacko
NPI 1922167303
$8,315.41
in general payments reported to CMS, 2019-2025
15 companies · $7,193 in 2025
The $7,193 reported for 2025 was more than what 89% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.50 · 2020: $81.10 · 2021: $156 · 2022: $218 · 2023: $351 · 2024: $238 · 2025: $7,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,475 · Food and Beverage: $1,408 · Travel and Lodging: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,475.00 |
| Food and Beverage | $1,407.97 |
| Travel and Lodging | $899.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $7,152.66 | 2021-2025 | Susvimo, Vabysmo |
| Ani Pharmaceuticals, INC. | $468.02 | 2024-2025 | Iluvien, Purified Cortrophin Gel, Yutiq |
| Astellas Pharma US INC | $120.94 | 2023 | |
| Apellis Pharmaceuticals, INC. | $109.54 | 2023-2025 | Syfovre |
| Alcon Vision LLC | $93.99 | 2023-2024 | Constellation |
| Biogen, INC. | $80.98 | 2022-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $52.03 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $47.79 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $37.66 | 2020 | |
| Mallinckrodt Hospital Products INC. | $37.39 | 2025 | Acthar |
| Bausch & Lomb Americas INC. | $30.61 | 2022 | |
| Allergan, INC. | $30.25 | 2019-2020 | |
| Eyepoint US, INC. | $21.28 | 2021 | |
| Abbvie INC. | $17.35 | 2025 | |
| Mallinckrodt Enterprises LLC | $14.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Chacko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.